Latest California Healthline Stories
New Medicare Advantage Tool To Lower Drug Prices Puts Crimp In Patients’ Choices
Federal officials are allowing the private insurance plans to use “step therapy” for drugs administered by doctors. In step therapy, patients must first use cheaper drugs to see if they work before receiving more expensive options.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Paper Jam: California’s Medicaid Program Hits ‘Print’ When The Feds Need Info
Amid the buzz over apps and electronic medical records rescuing modern medicine, California’s Medicaid program still clings to 1970s-era technology. A reboot may cost half a billion dollars.
La “medicina de precisión” para combatir el cáncer no siempre logra su objetivo
Estas terapias focalizadas, que ajustan la medicina a la genética de la enfermedad, no tienen el éxito que los médicos, y el público en general, esperan.
Much Touted For Cancer, ‘Precision Medicine’ Often Misses The Target
Doctors and hospitals love to talk about the patients they’ve saved with precision medicine, and reporters love to write about them. But the people who die still vastly outnumber the rare successes.
¿Como la diabetes? Legisladores buscan nuevas formas de tratar adicción a opioides
Un proyecto de ley requeriría que las aseguradoras privadas cubrieran los medicamentos para la adicción a los opioides sin necesidad de aprobación previa.
Insulin’s Steep Price Leads To Deadly Rationing
Alec Raeshawn Smith was 23 when diagnosed with Type 1 diabetes, and 26 when he died. He couldn’t afford $1,300 per month for his insulin and other diabetes supplies. So he tried to stretch the doses.
As Treatable As Diabetes? Lawmakers Push New Ways To Stem Opioid Addiction
California lawmakers approved 14 measures to address the opioid crisis, including one that requires health plans to cover medication-based treatments for opioid addiction without requiring pre-authorization. Gov. Jerry Brown has until the end of September to approve or reject the proposals.
The High Cost Of Hope: When The Parallel Interests Of Pharma And Families Collide
Desperate for help in finding a lifesaving drug for a fatal genetic disease, families banded together to fund early research and then worked with drug companies on clinical trials and marketing. Yet, this small patient advocacy group is stunned by pharma’s pricing.
As California Hospitals Sweep Up Physician Practices, Patients See Higher Bills
A Health Affairs study quantifies the financial effects of such mergers on consumers and their insurers. The hospital industry and doctor practices say the consolidation leads to better coordination of care.